Grant: DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)
Université de Montréal
$120,000.00
Characterisation of Bone Marrow Stromal Cell-Mediated Chemo-resistance in Acute Myeloid Leukemia using in vitro Co-culture
EF 2025-26
Résumé
Leukemias are the most common type of cancer in young children with acute myeloid leukemia representing about 20% of cases. Drug resistance remains a major problem in childhood acute myeloid leukemia, leading to a survival rate of only about 60%. One form of this drug resistance is the interactions between the leukemia cells and their environment in the bone marrow. Combining leukemia cells with one of the other cell types from the bone marrow has been used to study this effect which showed that drugs commonly used to treat people with this disease were less effective in the leukemia and bone marrow cell combination compared to the leukemia cells alone. Our lab identified 70 potential drugs that had the ability to target leukemia cells when they are alone. However, when the leukemia cells are instead cultured with the cells from the bone marrow, about one third seem to lose their effectiveness. The goals of my project are to understand precisely what is happening when the bone marrow cells are present and to identify the proteins on the leukemia cells that interact with the bone marrow cells and contribute to the drug resistance. I have observed that some of the leukemia cells we commonly use in the lab become dormant when the bone marrow cells are present. I plan to isolate these dormant cells to see if they play a role in the drug resistance. I will also test the 70 potential drugs against the leukemia cells with the bone marrow cells. CRISPR technology will then be used to individually delete a series of proteins in the presence of drugs that showed resistance. This will determine whether or not the protein that was deleted was involved in the drug resistance. This can be seen as the effectiveness of the drug will be increased when a protein contributing to the resistance is removed. In conclusion, this work will help identify and understand drug resistance in acute myeloid leukemia, which in the future could potentially be used as targets for treatment.
Programme
DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
559355
Name
Lussier Tyler E
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
DT1 (Biomedical and/or Clinical Research) CGRS Doctoral
Projecttitle
Characterisation of Bone Marrow Stromal Cell-Mediated Chemo-resistance in Acute Myeloid Leukemia using in vitro Co-culture
Programtype2
Studentship Programs
Orgnameinp2
Université de Montréal
Cihramount2
$120,000
Cihrequipment2
$0
Programname2
DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)
Keyworddelim
Acute Myeloid Leukemia; Bone Marrow Microenvironment; Cell-Cell Interactions; Co-Culture; Drug Resistance; Flow Cytometry; High-Throughput Screening; Pediatric Leukemias; Targeted Crispr Screen; Transcriptomics
Abstract
Leukemias are the most common type of cancer in young children with acute myeloid leukemia representing about 20% of cases. Drug resistance remains a major problem in childhood acute myeloid leukemia, leading to a survival rate of only about 60%. One form of this drug resistance is the interactions between the leukemia cells and their environment in the bone marrow. Combining leukemia cells with one of the other cell types from the bone marrow has been used to study this effect which showed that drugs commonly used to treat people with this disease were less effective in the leukemia and bone marrow cell combination compared to the leukemia cells alone. Our lab identified 70 potential drugs that had the ability to target leukemia cells when they are alone. However, when the leukemia cells are instead cultured with the cells from the bone marrow, about one third seem to lose their effectiveness. The goals of my project are to understand precisely what is happening when the bone marrow cells are present and to identify the proteins on the leukemia cells that interact with the bone marrow cells and contribute to the drug resistance. I have observed that some of the leukemia cells we commonly use in the lab become dormant when the bone marrow cells are present. I plan to isolate these dormant cells to see if they play a role in the drug resistance. I will also test the 70 potential drugs against the leukemia cells with the bone marrow cells. CRISPR technology will then be used to individually delete a series of proteins in the presence of drugs that showed resistance. This will determine whether or not the protein that was deleted was involved in the drug resistance. This can be seen as the effectiveness of the drug will be increased when a protein contributing to the resistance is removed. In conclusion, this work will help identify and understand drug resistance in acute myeloid leukemia, which in the future could potentially be used as targets for treatment.
Competitiondate
202511
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Lussier, Tyler E
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $120,000~ $0~